<ѻý>FDA Expands Approval of Osimertinib in Lung Cancerѻý> EGFR inhibitor now indicated for unresectable stage III disease following chemoradiotherapy Sep 25, 2024
<ѻý>Cancer Diagnoses Slow to Recover From Effects of COVID Pandemicѻý> Actual rates for 2021 lagged behind projections Sep 25, 2024
<ѻý>Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxisѻý> Fidanacogene elaparvovec reduces bleeding episodes by 71% after a single infusion Sep 25, 2024
<ѻý>Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancerѻý> Strategy comes with associated "low risk" of delay in diagnosis of advanced or incurable cancers Sep 25, 2024
<ѻý>'Sex Party' COVID Czar Fired; Undiagnosed Iron Deficiency; Many Papers Partly Fake?ѻý> Health news and commentary gathered by ѻý staff Sep 25, 2024
<ѻý>ASCO's Quality Care Symposium: Chemotherapy Shortage Resulted in Higher Costsѻý> Other studies look at financial toxicity for teen/young adult cancer patients, nausea after chemo Sep 24, 2024
<ѻý>Immunotherapy May Not Benefit All Gastroesophageal Cancer Patients, FDA Staff Saysѻý> Data since approvals suggest benefits limited to subgroups with PD-L1 expression of at least 1% Sep 24, 2024
<ѻý>EPA Scientists Say They Were Pressured to Downplay Health Harms From Chemicalsѻý> And a watchdog found they were retaliated against Sep 22, 2024
<ѻý>High ADHD Medication Doses Tied to Psychosis; Rapid Tests for Malariaѻý> Also in TTHealthWatch: youth and opioids, and pembrolizumab for triple-negative breast cancer Sep 21, 2024 podcast
<ѻý>Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?ѻý> News, features, and commentary about cancer-related issues Sep 19, 2024
<ѻý>Rucaparib-Nivolumab Maintenance Not the Answer in Newly Diagnosed Ovarian Cancerѻý> Poorer survival outcomes plus more toxicity versus rucaparib alone Sep 18, 2024
<ѻý>Novel Agent Effective for Cancer Wasting Disorderѻý> Cancer patients with cachexia added needed pounds with GDF-15 antibody Sep 18, 2024
<ѻý>Lymphedema Risk No Higher With 3-Week RT Regimen in Early Breast Cancerѻý> "Nodal radiotherapy for breast cancer no longer needs 5 weeks," researcher says Sep 17, 2024
<ѻý>FDA Expands Approval of Ribociclib to Early Breast Cancerѻý> Broad indication doubles the number of patients eligible for adjuvant CDK4/6 inhibition Sep 17, 2024
<ѻý>Survival Win for Pembrolizumab in Early Triple-Negative Breast Cancerѻý> Absolute difference of 4.9% at 5 years, including a benefit for patients who did not achieve pCR Sep 17, 2024
<ѻý>Cabozantinib Improves PFS for Advanced Neuroendocrine Tumorsѻý> Potential new option for patients with previously treated extrapancreatic or pancreatic NETs Sep 17, 2024
<ѻý>Digital Breast Tomosynthesis May Reduce Development of Advanced Cancersѻý> Retrospective study suggests benefits over digital mammography Sep 17, 2024
<ѻý>Win for Perioperative Durvalumab in Muscle-Invasive Bladder Cancerѻý> Results "practice-changing," says expert Sep 16, 2024
<ѻý>Medical Cannabinoids in Kids Linked to These Adverse Eventsѻý> Meta-analysis points to considerations for use and what to monitor Sep 16, 2024
<ѻý>Another Possible Treatment Option for Intermediate-Stage Liver Cancerѻý> Adding lenvatinib, pembrolizumab to TACE significantly improved PFS, numerically improved OS Sep 16, 2024
<ѻý>Chemo-Free Triplet Yields 68% Response Rate in Richter Transformationѻý> Regimen tops best historical response rate with chemoimmunotherapy in this setting Sep 16, 2024
<ѻý>Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survivalѻý> Hazards for radiographic PFS, OS reduced by 31% with enzalutamide plus Ra-223 Sep 15, 2024
<ѻý>Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancerѻý> POD1UM-303/InterAACT 2 data also trend in the direction of better overall survival Sep 15, 2024
<ѻý>No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancerѻý> But combination may be appropriate for shrinking tumors before surgery Sep 14, 2024
<ѻý>Another Win for Antibody-Drug Conjugate in HER2+ Breast Cancer With Brain Metsѻý> Second-line T-DXd best option in patients with and without intracranial activity, experts says Sep 14, 2024
<ѻý>Screening After False Positive Mammograms; RSV Vaccination and Hospitalizationѻý> Also in TTHealthWatch: time from approval to reimbursement for new drugs Sep 14, 2024 podcast
<ѻý>No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinomaѻý> Data support that ICI rechallenge should be discouraged in patients with advanced RCC Sep 13, 2024
<ѻý>Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancerѻý> News, features, and commentary about cancer-related issues Sep 12, 2024
<ѻý>How a California Oncologist Making $850k Spends Moneyѻý> See the breakdown of this physician's weekly budget, from eating out to sailing lessons Sep 12, 2024
<ѻý>Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatmentsѻý> Incidence almost identical to that with standard cancer treatment in randomized trials Sep 11, 2024
<ѻý>Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLCѻý> Objective response rate was 55% with 12-mg/kg ifinatamab deruxtecan Sep 11, 2024
<ѻý>Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctorsѻý> "This is sort of the dirty underbelly of the current healthcare environment," an oncologist said Sep 11, 2024
<ѻý>Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLCѻý> However, plinabulin plus docetaxel still "not ready for prime time," expert says Sep 10, 2024
<ѻý>MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLCѻý> Absolute improvement of almost 30%, doubling of duration of response with savolitinib Sep 10, 2024
<ѻý>Did U.S. Government Play a Role in Remote Tribe's Widespread Illness and Cancer?ѻý> Toxins are embedded in the soil, but no one can say what has caused such widespread illness Sep 10, 2024
<ѻý>Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLCѻý> Two-trial analysis shows about a 40% decreased risk of disease recurrence or death Sep 09, 2024
<ѻý>Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCDѻý> For patients with vaso-occlusive episodes, lactated Ringer was better than normal saline Sep 09, 2024
<ѻý>Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLCѻý> Novel agent nearly halved risk of progression as first-line therapy in phase III trial Sep 09, 2024
<ѻý>Kate Middleton Reaches Cancer Treatment Milestoneѻý> Princess of Wales says she will return to some public duties Sep 09, 2024
<ѻý>Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancerѻý> Add-on ADC, monoclonal antibody consistently increase pCR versus PD-1 inhibitor plus chemotherapy Sep 09, 2024